Lorazepam to prevent delirium in intensive care patients
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests whether giving a low dose of lorazepam, a calming medicine, can help prevent delirium (confusion and agitation) in patients newly admitted to the intensive care unit (ICU). It may help patients recover more smoothly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You were admitted to the ICU as an emergency or unplanned admission.
- You have been in the ICU for less than 24 hours and in the hospital for less than 24 hours before that.
- You have a certain risk score (called Anttila-Index) of 4 or higher, which means you are at higher risk for delirium.
- You are not currently taking benzodiazepines (a class of sedative medicines) and do not need them for your condition.
- You are not pregnant or breastfeeding, and you have no allergy to lorazepam.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special sleep-promoting protocol (using eye masks, earplugs, and other measures) to help prevent delirium (sudden confusion) in intensive care patients. If you or a loved one are in the ICU, this treatment might help reduce confusion and improve recovery.
This trial tests whether giving melatonin (or a placebo) can help adults in the intensive care unit who have a specific type of confusion called low-activity delirium. It aims to improve recovery by supporting sleep–wake regulation in the ICU.
This Phase 2 trial tests whether melatonin can reduce delirium, a sudden confusion that can happen in the ICU. If you qualify, you may be given melatonin to see if it improves alertness and comfort during an expected longer ICU stay.
This study compares two sedative medicines to see which one causes less confusion or delirium in older adults after heart valve surgery. Participants will be randomly assigned to receive one of the two medications during their surgery.
This trial tests if giving melatonin (a natural sleep hormone) can help prevent delirium (sudden confusion) in older adults who are hospitalized. It may help you if you are 65 or older and admitted to the hospital for general medical care.
This study tests whether a sleep medication called lemborexant can help older patients in the ICU sleep better and prevent post-surgery confusion. It may be a good fit if you are over 65 and will be in the ICU for at least two days after surgery.
Hear when a new Delirium Confusional State trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.